Wilzin

zinc · Recordati Rare Diseases
AUTHORISED IN THE EU

What Wilzin is used for

Treatment of Wilson's disease.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Wilzin
Active substance
zinc
Disease area
Hepatolenticular Degeneration
Medicine group
Other alimentary tract and metabolism products
ATC code
A16AX05
Marketing authorisation holder
Recordati Rare Diseases
Authorised in the EU since
2004

Official information

In India

  • Zinc: 42 brands in India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Wilzin used for?

Treatment of Wilson's disease.

What is the active substance in Wilzin?

Wilzin contains zinc.

Who makes Wilzin?

The EU marketing authorisation holder is Recordati Rare Diseases.

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.